Scantox is proud to participate in the Bio-Neuroscience 2027 Summit in Amsterdam as a Bronze Sponsor, building on our successful presence at last year’s event. The summit brings together researchers, biotechnology companies, pharmaceutical innovators, and drug development experts to explore the latest advances in neuroscience.
As the neuroscience field continues to advance through breakthroughs in disease modelling, biomarker discovery, gene and cell therapies, and precision medicine approaches, the need for robust preclinical evaluation remains critical. Scantox supports neuroscience innovators throughout the drug development journey with specialized preclinical services, and we look forward to engaging with the scientific community to discuss emerging therapeutic strategies and how high-quality preclinical data can help accelerate the development of treatments for patients with unmet neurological needs.
Meet our team in Amsterdam to learn how Scantox can support your neuroscience programs from discovery through regulatory submission.
